- Home
- PRU vs ONC Comparison
PRU vs ONC Comparison
Compare PRU & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRU
- ONC
- Stock Information
- Founded
- PRU 1875
- ONC 2010
- Country
- PRU United States
- ONC Switzerland
- Employees
- PRU N/A
- ONC N/A
- Industry
- PRU Life Insurance
- ONC Biotechnology: Pharmaceutical Preparations
- Sector
- PRU Finance
- ONC Health Care
- Exchange
- PRU Nasdaq
- ONC Nasdaq
- Market Cap
- PRU 36.5B
- ONC 34.8B
- IPO Year
- PRU N/A
- ONC N/A
- Fundamental
- Price
- PRU $108.61
- ONC $340.52
- Analyst Decision
- PRU Hold
- ONC Strong Buy
- Analyst Count
- PRU 12
- ONC 12
- Target Price
- PRU $120.73
- ONC $369.50
- AVG Volume (30 Days)
- PRU 1.9M
- ONC 330.8K
- Earning Date
- PRU 10-29-2025
- ONC 11-06-2025
- Dividend Yield
- PRU 5.00%
- ONC N/A
- EPS Growth
- PRU N/A
- ONC N/A
- EPS
- PRU 7.27
- ONC 0.29
- Revenue
- PRU $57,598,000,000.00
- ONC $4,998,489,124.00
- Revenue This Year
- PRU N/A
- ONC $35.34
- Revenue Next Year
- PRU $3.85
- ONC $22.45
- P/E Ratio
- PRU $14.85
- ONC $1,142.28
- Revenue Growth
- PRU N/A
- ONC 53.47
- 52 Week Low
- PRU $90.38
- ONC $170.99
- 52 Week High
- PRU $130.55
- ONC $385.22
- Technical
- Relative Strength Index (RSI)
- PRU 62.51
- ONC 51.11
- Support Level
- PRU $101.22
- ONC $322.41
- Resistance Level
- PRU $107.94
- ONC $345.58
- Average True Range (ATR)
- PRU 1.87
- ONC 14.49
- MACD
- PRU 0.28
- ONC -2.20
- Stochastic Oscillator
- PRU 94.34
- ONC 29.94
About PRU Prudential Financial Inc.
Prudential Financial is one of the largest US life insurers, offering annuities, life insurance, and asset-management products. The United States and Japan are its two largest markets. Its US business contributed about 50% of adjusted 2024 earnings and includes institutional retirement (mostly pension risk transfer), individual retirement (annuities), group insurance, and individual life insurance. Its international business represented about 40% of adjusted earnings, with a strong market position in Japan, and the firm also has a presence in emerging markets like Brazil. The company's investment management business, PGIM, contributed approximately 10% of its 2024 adjusted earnings and has around $1.4 trillion in assets under management.
About ONC BeiGene Ltd. American Depositary Shares
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.